Area of research
Radiology, Nuclear Medicine and Imaging · Otorhinolaryngology
Research interest
Research interests include Medical Imaging Techniques and Applications, Radiomics and Machine Learning in Medical Imaging, Head and Neck Cancer Studies, and Radiopharmaceutical Chemistry and Applications.
An artificial intelligence method using FDG PET to predict treatment outcome in diffuse large B cell lymphoma patients
Proposed New Dynamic Prognostic Index for Diffuse Large B-Cell Lymphoma: International Metabolic Prognostic Index
Optimal timing and criteria of interim PET in DLBCL: a comparative study of 1692 patients
Automated Segmentation of Baseline Metabolic Total Tumor Burden in Diffuse Large B-Cell Lymphoma: Which Method Is Most Successful? A Study on Behalf of the PETRA Consortium
Rituximab-CHOP With Early Rituximab Intensification for Diffuse Large B-Cell Lymphoma: A Randomized Phase III Trial of the HOVON and the Nordic Lymphoma Group (HOVON-84)
Optimizing Workflows for Fast and Reliable Metabolic Tumor Volume Measurements in Diffuse Large B Cell Lymphoma
Lesion detection by [89Zr]Zr-DFO-girentuximab and [18F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial
[89Zr]Zr-cetuximab PET/CT as biomarker for cetuximab monotherapy in patients with RAS wild-type advanced colorectal cancer
Use of modern imaging methods to facilitate trials of metastasis-directed therapy for oligometastatic disease in prostate cancer: a consensus recommendation from the EORTC Imaging Group
Diagnostic value of diffusion-weighted imaging and 18F-FDG-PET/CT for the detection of unknown primary head and neck cancer in patients presenting with cervical metastasis
Feasibility of intraoperative detection of sentinel lymph nodes with 89-zirconium-labelled nanocolloidal albumin PET-CT and a handheld high-energy gamma probe
iRECIST: guidelines for response criteria for use in trials testing immunotherapeutics
Diagnostic Accuracy of Neuroimaging to Delineate Diffuse Gliomas within the Brain: A Meta-Analysis
RECIST 1.1—Update and clarification: From the RECIST committee
Imaging biomarker roadmap for cancer studies
RECIST 1.1 – Standardisation and disease-specific adaptations: Perspectives from the RECIST Working Group
Randomized phase III study on the effect of early intensification of rituximab in combination with 2-weekly CHOP chemotherapy followed by rituximab or no maintenance in patients with diffuse large B-cell lymphoma: Results from a HOVON-Nordic Lymphoma Group study.
Summary of the UPICT Protocol for <sup>18</sup>F-FDG PET/CT Imaging in Oncology Clinical Trials
Quantitative Comparison of <sup>124</sup>I PET/CT and <sup>131</sup>I SPECT/CT Detectability
FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0
Role of Imaging in the Staging and Response Assessment of Lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group
Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma
Stability of FDG-PET Radiomics features: An integrated analysis of test-retest and inter-observer variability